Erianin induces apoptosis and pyroptosis via MAPK/ERK and PI3K/Akt pathways and synergizes with anlotinib in anaplastic thyroid carcinoma. The gene discussed is AKT1; the disease is thyroid gland undifferentiated (anaplastic) carcinoma.